You are here: Industry Insights > acquisition

News List

European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius prnasia
March 20, 2020
The businesses to be acquired are part of Danaher's Life Sciences platform and include various laboratory and bioprocessing technologies that are complementary to the portfolios of both Sartorius divisions.
AcelRx to Acquire Tetraphase americanpharmaceuticalreview
March 19, 2020
AcelRx Pharmaceuticals announced a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock for stock deal at an exchange ratio of 0.6303 shares of AcelRx ...
Bormioli Pharma to Acquire GCL Pharma for €8.9M contractpharma
March 19, 2020
Expands industrial footprint by adding new technologies to extend its oral and parenteral product range.
Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility contractpharma
March 10, 2020
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora will acquire GSK’s Mississauga, Ontario (Canada) facility.
Bactiguard Completes Acquisition of Vigilenz prnasia
March 03, 2020
Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.
Merck closes $2.7bn acquisition of biopharmaceutical firm ArQule pharmaceutical-technology
January 19, 2020
Merck (MSD) has completed its previously announced acquisition of US-based biopharmaceutical company ArQule. The $2.7bn deal closed following completion of the cash tender offer that involved acquiring ArQule’s outstanding shares of common stock at $20 pe
WuXi Biologics to acquire drug manufacturing plant in Germany pharmaceutical-technology
January 19, 2020
WuXi Biologics has signed an acquisition agreement to take over a Bayer’s drug product manufacturing plant in Leverkusen, Germany. The Leverkusen plant will be the Chinese firm’s first drug product facility in Europe bolstering its commercial manufacturin
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany(1) PharmaSources/Wuxi Biologics
January 16, 2020
WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer
Astellas Completes Acquisition of Audentes Therapeutics americanpharmaceuticalreview
January 16, 2020
Astellas Pharma has successfully completed the previously announced acquisition of Audentes Therapeutics, through a tender offer by its indirect wholly-owned subsidiary Asilomar Acquisition for all of the issued and outstanding shares of common stock of .
Lilly to acquire Dermira for approximately $1.1bn pharmaceutical-technology
January 14, 2020
Eli Lilly and Company (Lilly) has signed a definitive agreement to acquire biopharmaceutical firm Dermira for approximately $1.1bn in cash. As agreed, Lilly will acquire all outstanding shares of Dermira for $18.75 per share.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page